• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ULTRAFLEX ESOPHAGEAL NG; PROSTHESIS, ESOPHAGEAL Back to Search Results
Model Number M00513850
Device Problems Positioning Failure (1158); Failure to Advance (2524); Material Deformation (2976)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/31/2023
Event Type  malfunction  
Manufacturer Narrative
Block a2: patient's exact age is unknown; however, it was reported that the patient was over the age of 18.Block h6: impact code f1001 is being used to capture the reportable issue of aborted/cancelled procedure.
 
Event Description
It was reported to boston scientific corporation on april 12, 2023, that an ultraflex esophageal ng proximal release covered stent was implanted to treat esophageal stenosis due to esophageal cancer during an esophageal stent placement procedure performed on (b)(6) 2023.The patient anatomy was tortuous and not dilated prior to stent placement, during the procedure, the device could not be advanced through the stenosis.Dilation was attempted and a new maneuver was performed to implant the stent.However, the stent was unable to cross the stenosis even after several attempts and the distal part of the delivery shaft was noted to be bent.The stent was removed from the patient fully covered by the stent deployment suture, and the procedure was not completed due to this event.There were no patient complications reported as a result of this event.The patient condition following the procedure was reported to be stable.
 
Manufacturer Narrative
Block a2: patient's exact age is unknown; however, it was reported that the patient was over the age of 18.Block h6: impact code f1001 is being used to capture the reportable issue of aborted/cancelled procedure.Block h10: the ultraflex esophageal ng proximal covered stent and delivery system were received for analysis.Visual inspection revealed that the stent was partially deployed, and the shaft was bent.The outer diameter of the stent delivery system was measured and was found to be within specifications.No other damage was noted to the stent or the delivery system.Product analysis confirmed the reported event of shaft bent.However, the reported event of the delivery system being difficult to cross lesion could not be confirmed because this event occurred during the procedure and was not possible to replicate in the laboratory of analysis.The investigation concluded that the reported events and the observed failure were most likely due to procedural factors, such as lesion characteristics, handling of the device, and the technique used in several attempts to cross the lesion.These procedural factors may have limited the performance of the device and contributed to stent partial deployment.Therefore, a review and analysis of all available information indicated that the most probable cause is adverse event related to procedure.A product labeling review identified that the device was used per the instructions for use (ifu)/product label.Block h11: correction to the initial mdr in block h6 (device codes).
 
Event Description
It was reported to boston scientific corporation on (b)(6) 2023, that an ultraflex esophageal ng proximal release covered stent was implanted to treat esophageal stenosis due to esophageal cancer during an esophageal stent placement procedure performed on (b)(6) 2023.The patient anatomy was tortuous and not dilated prior to stent placement, during the procedure, the device could not be advanced through the stenosis.Dilation was attempted and a new maneuver was performed to implant the stent.However, the stent was unable to cross the stenosis even after several attempts and the distal part of the delivery shaft was noted to be bent.The stent was removed from the patient fully covered by the stent deployment suture, and the procedure was not completed due to this event.There were no patient complications reported as a result of this event.The patient condition following the procedure was reported to be stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ULTRAFLEX ESOPHAGEAL NG
Type of Device
PROSTHESIS, ESOPHAGEAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key16896525
MDR Text Key314852055
Report Number3005099803-2023-02325
Device Sequence Number1
Product Code ESW
UDI-Device Identifier08714729716075
UDI-Public08714729716075
Combination Product (y/n)N
Reporter Country CodeUY
PMA/PMN Number
K091816
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 07/20/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/09/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM00513850
Device Catalogue Number1385
Device Lot Number0029916739
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/29/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured08/09/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-